XA
Longevity Health Holdings Inc.
XAGE · OTC
$0.17 +0.00% (+$0.00)
1M -19.09%
Market Cap $243.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.14x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 54.63%
Net margin 404.84%
FCF margin 146.06%
Quality
79 /100
Excellent ROIC 72.37%
ROA 647.05%
Asset turnover 1.60x
Debt
0 /100
High Current ratio 0.07x
Int. coverage -353.83x
Debt/Equity N/A
Stability
19 /100
Unstable Beta 0.40x
EPS volatility 402.82%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o XAGE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Janakiram Ajjarapu
Employees
10
Headquarters
Pittsburgh